Angiogenesis in primary central nervous system lymphoma (PCNSL)

Journal of Neuro-Oncology

Volumn 84, Issue 2, 2007, Pages 141-145

  Takeuchi, Hiroaki ^a   Matsuda, Ken ^a   Kitai, Ryuhei ^a   Sato, Kazufumi ^a   Kubota, Toshihiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Angiogenesis; Blood brain barrier; Primary central nervous system lymphoma; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CANCER SURVIVAL; CAPILLARY ENDOTHELIUM; CELL INFILTRATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOMA CELL; MALE; MICROVASCULATURE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TIGHT JUNCTION; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM NEOPLASMS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547627009     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9363-x     Document Type: Article

References (14)

1. Bairey O, Zimra Y, Kaganovsky E, Shaklai M, Okon E, Rabizadeh E (2000) Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas. Med Oncol 17(4):314-318
2. Bertolini F, Paolucci M, Peccatori F, Cinieri S, Agazzi A, Ferrucci PF, Cocorocchio E, Goldhirsch A, Martinelli G (1999) Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol 106(2):504-509
3. Bono P, Teerenhovi L, Joensuu H (2003) Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Cancer 97(11):2767-2775
4. Hazar B, Paydas S, Zorludemir S, Sahin B, Tuncer I (2003) Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma. Leuk Lymphoma 44(12):2089-2093
5. Ho CL, Sheu LF, Li CY (2002) Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 10(4):316-321
6. List AF (2001) Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist 6(3):24-31
7. Paulus W (1999) Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 43:203-208
8. Ranieri G, Patruno R, Lionetti A, Di Summa A, Mattioli E, Bufo P, Pellecchia A, Ribatti D, Zizzo N (2005) Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: An interspecies model of tumor angiogenesis. Leuk Lymphoma 46(11):1639-1643
9. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F (1996) Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 56(1):45-53
10. Ridell B, Norrby K (2001) Intratumoral microvascular density in malignant lymphomas of B-cell origin. APMIS 109(1):66-72
11. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M (2002) Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 58(1):53-56
12. Salven P, Teerenhovi L, Joensuu H (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90(8):3167-3172
13. Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43(3):199-201
14. Vacca A, Ribatti D, Ruco L, Giacchetta F, Nico B, Quondamatteo F, Ria R, Iurlaro M, Dammacco F (1999) Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer 79(5):965-970